Brendan K. Podell

Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens

Nicholas D. Walter, Sarah E. M. Born, Gregory T. Robertson et al. · Nature Communications · 2021 · 88 citations · Full text

Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832

Gregory T. Robertson, Michelle E. Ramey, Lisa M. Massoudi et al. · Antimicrobial Agents and Chemotherapy · 2021 · 76 citations · Full text

Tuberculosis Treatment, Drug Target, Dpre1 Inhibitors Tba-7371 +19

Increased Severity of Tuberculosis in Guinea Pigs with Type 2 Diabetes

Brendan K. Podell, David F. Ackart, Andrés Obregón‐Henao et al. · American Journal Of Pathology · 2014 · 76 citations · Full text

Expression of antimicrobial drug tolerance by attached communities of<i>Mycobacterium tuberculosis</i>

David F. Ackart, Laurel Hascall-Dove, Silvia M. Caceres et al. · Pathogens and Disease · 2014 · 75 citations · Full text

Restored Drug Susceptibility, Tuberculosis Prevention, Attached Communities +22

GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus

Mary Ann De Groote, LaRue W. Johnson, Brendan K. Podell et al. · Journal of Antimicrobial Chemotherapy · 2013 · 67 citations · Full text